Literature DB >> 11879144

Insights into the pathogenesis of thyroid-associated orbitopathy: evolving rationale for therapy.

Michael Kazim1, Robert A Goldberg, Terry J Smith.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 11879144     DOI： 10.1001/archopht.120.3.380

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  32 in total

1.  Thyroid associated ophthalmopathy: evidence for CD4(+) gammadelta T cells; de novo differentiation of RFD7(+) macrophages, but not of RFD1(+) dendritic cells; and loss of gammadelta and alphabeta T cell receptor expression.

Authors:  A K Eckstein; B Quadbeck; S Tews; K Mann; C Krüger; C H Mohr; K-P Steuhl; J Esser; R K Gieseler
Journal:  Br J Ophthalmol       Date:  2004-06       Impact factor: 4.638

Review 2.  [Endocrine orbit disorders. Pathogenesis, clinical presentation and examination, stage-dependent therapy].

Authors:  A Eckstein; J Esser
Journal:  Ophthalmologe       Date:  2003-10       Impact factor: 1.059

3.  Fibroblasts expressing the thyrotropin receptor overarch thyroid and orbit in Graves' disease.

Authors:  Terry J Smith; Dolly A Padovani-Claudio; Ying Lu; Nupur Raychaudhuri; Roshini Fernando; Stephen Atkins; Erin F Gillespie; Andrew G Gianoukakis; Barbra S Miller; Paul G Gauger; Gerard M Doherty; Raymond S Douglas
Journal:  J Clin Endocrinol Metab       Date:  2011-09-28       Impact factor: 5.958

Review 4.  TSH-receptor-expressing fibrocytes and thyroid-associated ophthalmopathy.

Authors:  Terry J Smith
Journal:  Nat Rev Endocrinol       Date:  2015-01-06       Impact factor: 43.330

5.  Divergent Sp1 protein levels may underlie differential expression of UDP-glucose dehydrogenase by fibroblasts: role in susceptibility to orbital Graves disease.

Authors:  Shanli Tsui; Roshini Fernando; Beiling Chen; Terry J Smith
Journal:  J Biol Chem       Date:  2011-05-16       Impact factor: 5.157

6.  Pentraxin-3 Is a TSH-Inducible Protein in Human Fibrocytes and Orbital Fibroblasts.

Authors:  Hao Wang; Stephen J Atkins; Roshini Fernando; Rui-Li Wei; Terry J Smith
Journal:  Endocrinology       Date:  2015-08-19       Impact factor: 4.736

7.  Reactivation of thyroid-associated orbitopathy after cataract surgery.

Authors:  Joseph M Shadpour; Ravi M Menghani; Raymond S Douglas; Robert A Goldberg; Angelo Tsirbas
Journal:  Jpn J Ophthalmol       Date:  2009-01-30       Impact factor: 2.447

Review 8.  Orbital inflammation.

Authors:  Kimberly P Cockerham; Sang H Hong; Ellen E Browne
Journal:  Curr Neurol Neurosci Rep       Date:  2003-09       Impact factor: 5.081

Review 9.  Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy.

Authors:  Terry J Smith; Chieh Chih Tsai; Mei-Ju Shih; Shanli Tsui; Beiling Chen; Rui Han; Vibha Naik; Chris S King; Chris Press; Shweta Kamat; Robert A Goldberg; Richard P Phipps; Raymond S Douglas; Andrew G Gianoukakis
Journal:  Thyroid       Date:  2008-09       Impact factor: 6.568

10.  Postoperative drift in patients with thyroid ophthalmopathy undergoing unilateral inferior rectus muscle recession.

Authors:  Jason H Peragallo; Federico G Velez; Joseph L Demer; Stacy L Pineles
Journal:  Strabismus       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.